Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562 |
Resumo: | Background: Autonomic nervous system dysfunction is commonly seen in multiple sclerosis patients and should be explored in the routine evaluation. Composite Autonomic Symptom Score questionnaire was validated as a self-assessment instrument of autonomic symptoms.Objectives: Determine the frequency of autonomic symptoms in multiple sclerosis patients through a Portuguese version of Composite Autonomic Symptom Score; compare questionnaire results between patients and a control group; assess the feasibility of this questionnaire application in multiple sclerosis Portuguese patients.Material and Methods: This case-control study used a Portuguese translated version of Composite Autonomic Symptom Score to determine the frequency of autonomic symptoms in multiple sclerosis patients.Results: One-hundred and three relapsing-remitting multiple sclerosis patients – median age 41 years, median disease duration 6 years, median EDSS score 1 - and 80 healthy subjects were included. Alterations in autonomic function were reported in 97.1% of the cases, with statistical significance in orthostatic intolerance and gastrointestinal domain scores. Nevertheless, the difference between multiple sclerosis patients (41.7%) without confounding factors that could interfere with autonomic dysfunction (i.e. comorbidities or medications) and controls showed no statistical significance.Discussion: Our results may be related to the short disease duration, young age and lowdisability status of our patients unaffected by confounding factors. The questionnaire was not designed specifically for multiple sclerosis and it may not be as sensible to early autonomic symptoms as to more severe manifestations.Conclusions: Further studies are needed to achieve more robust results, validate this questionnaire and assess its application in multiple sclerosis patients in Portugal.Keywords: Autonomic Nervous System; Multiple Sclerosis; Portugal; Questionnaires. |
id |
RCAP_bfeaa6888e08718b6c3c49a3f7413114 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/5562 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Prevalence of Autonomic Dysfunction in Patients with Multiple SclerosisPrevalência da Disfunção Autonómica em Doentes com Esclerose MúltiplaBackground: Autonomic nervous system dysfunction is commonly seen in multiple sclerosis patients and should be explored in the routine evaluation. Composite Autonomic Symptom Score questionnaire was validated as a self-assessment instrument of autonomic symptoms.Objectives: Determine the frequency of autonomic symptoms in multiple sclerosis patients through a Portuguese version of Composite Autonomic Symptom Score; compare questionnaire results between patients and a control group; assess the feasibility of this questionnaire application in multiple sclerosis Portuguese patients.Material and Methods: This case-control study used a Portuguese translated version of Composite Autonomic Symptom Score to determine the frequency of autonomic symptoms in multiple sclerosis patients.Results: One-hundred and three relapsing-remitting multiple sclerosis patients – median age 41 years, median disease duration 6 years, median EDSS score 1 - and 80 healthy subjects were included. Alterations in autonomic function were reported in 97.1% of the cases, with statistical significance in orthostatic intolerance and gastrointestinal domain scores. Nevertheless, the difference between multiple sclerosis patients (41.7%) without confounding factors that could interfere with autonomic dysfunction (i.e. comorbidities or medications) and controls showed no statistical significance.Discussion: Our results may be related to the short disease duration, young age and lowdisability status of our patients unaffected by confounding factors. The questionnaire was not designed specifically for multiple sclerosis and it may not be as sensible to early autonomic symptoms as to more severe manifestations.Conclusions: Further studies are needed to achieve more robust results, validate this questionnaire and assess its application in multiple sclerosis patients in Portugal.Keywords: Autonomic Nervous System; Multiple Sclerosis; Portugal; Questionnaires.Introdução: A disfunção do sistema nervoso autónomo é comum na esclerose múltipla e deveria ser explorada na avaliação de rotina. O questionário Composite Autonomic Symptom Score foi validado como instrumento de auto-avaliação de sintomas autonómicos.Objetivos: Determinar a frequência de sintomas autonómicos em doentes com esclerose múltipla através de uma versão portuguesa do Composite Autonomic Symptom Score; comparar os resultados do questionário entre um grupo de doentes e um grupo controlo; avaliar a viabilidade da aplicação deste questionário em doentes portugueses.Material e Métodos: Neste estudo caso-controlo utilizou-se uma tradução portuguesa do questionário para determinar a frequência de sintomas autonómicos em doentes com esclerose múltipla.Resultados: Incluíram-se 103 doentes com esclerose múltipla surto-remissão – idade média 41 anos, mediana de duração da doença 6 anos, EDSS médio 1 - e 80 indivíduos saudáveis. Dos doentes, 97,1% tinham alterações da função autonómica, com significado estatístico nos domínios intolerância ortostática e gastrointestinal. Não encontramos diferenças estatísticas entre doentes (41,7%) sem fatores de confundimento que podiam interferir com a função autonómica (i.e. comorbilidades ou medicações) e o grupo controlo.Discussão: Os resultados obtidos podem estar relacionados com a curta duração de doença, idade jovem e baixo grau de incapacidade dos doentes sem fatores de confundimento. O questionário utilizado não foi desenhado especificamente para a esclerose múltipla e pode não ser tão sensível para sintomas autonómicos mais precoces como para manifestações mais graves da doença.Conclusões: Outros estudos serão necessários para obter resultados mais robustos, validar este questionário e avaliar a sua aplicação nos doentes portugueses.Palavras-chave: Esclerose Múltipla; Portugal; Questionários; Sistema Nervoso Autónomo.Ordem dos Médicos2015-02-27info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfimage/jpeghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562oai:ojs.www.actamedicaportuguesa.com:article/5562Acta Médica Portuguesa; Vol. 28 No. 1 (2015): January-February; 51-55Acta Médica Portuguesa; Vol. 28 N.º 1 (2015): Janeiro-Fevereiro; 51-551646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPengporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/4236https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/4213https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/7286https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/7287https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/7574Vieira, BitiaCosta, AndreiaVideira, GonçaloSá, Maria JoséAbreu, Pedroinfo:eu-repo/semantics/openAccess2022-12-20T11:04:24Zoai:ojs.www.actamedicaportuguesa.com:article/5562Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:07.409488Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis Prevalência da Disfunção Autonómica em Doentes com Esclerose Múltipla |
title |
Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis |
spellingShingle |
Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis Vieira, Bitia |
title_short |
Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis |
title_full |
Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis |
title_fullStr |
Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis |
title_full_unstemmed |
Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis |
title_sort |
Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis |
author |
Vieira, Bitia |
author_facet |
Vieira, Bitia Costa, Andreia Videira, Gonçalo Sá, Maria José Abreu, Pedro |
author_role |
author |
author2 |
Costa, Andreia Videira, Gonçalo Sá, Maria José Abreu, Pedro |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Vieira, Bitia Costa, Andreia Videira, Gonçalo Sá, Maria José Abreu, Pedro |
description |
Background: Autonomic nervous system dysfunction is commonly seen in multiple sclerosis patients and should be explored in the routine evaluation. Composite Autonomic Symptom Score questionnaire was validated as a self-assessment instrument of autonomic symptoms.Objectives: Determine the frequency of autonomic symptoms in multiple sclerosis patients through a Portuguese version of Composite Autonomic Symptom Score; compare questionnaire results between patients and a control group; assess the feasibility of this questionnaire application in multiple sclerosis Portuguese patients.Material and Methods: This case-control study used a Portuguese translated version of Composite Autonomic Symptom Score to determine the frequency of autonomic symptoms in multiple sclerosis patients.Results: One-hundred and three relapsing-remitting multiple sclerosis patients – median age 41 years, median disease duration 6 years, median EDSS score 1 - and 80 healthy subjects were included. Alterations in autonomic function were reported in 97.1% of the cases, with statistical significance in orthostatic intolerance and gastrointestinal domain scores. Nevertheless, the difference between multiple sclerosis patients (41.7%) without confounding factors that could interfere with autonomic dysfunction (i.e. comorbidities or medications) and controls showed no statistical significance.Discussion: Our results may be related to the short disease duration, young age and lowdisability status of our patients unaffected by confounding factors. The questionnaire was not designed specifically for multiple sclerosis and it may not be as sensible to early autonomic symptoms as to more severe manifestations.Conclusions: Further studies are needed to achieve more robust results, validate this questionnaire and assess its application in multiple sclerosis patients in Portugal.Keywords: Autonomic Nervous System; Multiple Sclerosis; Portugal; Questionnaires. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-02-27 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562 oai:ojs.www.actamedicaportuguesa.com:article/5562 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/5562 |
dc.language.iso.fl_str_mv |
eng por |
language |
eng por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/4236 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/4213 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/7286 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/7287 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/7574 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/vnd.openxmlformats-officedocument.wordprocessingml.document application/pdf image/jpeg |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 28 No. 1 (2015): January-February; 51-55 Acta Médica Portuguesa; Vol. 28 N.º 1 (2015): Janeiro-Fevereiro; 51-55 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130642311544832 |